Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: A case-control study

BMC Clinical Pathology

Volumn 13, Issue 1, 2013, Pages

  Xu, Qian ^a   Dong, Qi Guan ^a,b   Sun, Li Ping ^a   He, Cai Yun ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Biomarker; Gastric disease; Pepsinogen; Serum microRNA

Indexed keywords

MICRORNA; MICRORNA 20A 5P; MICRORNA 320A; MICRORNA LET 7A; PEPSINOGEN; UNCLASSIFIED DRUG;

ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

EID: 84875146969     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-13-11     Document Type: Article

References (47)

1. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
2. MicroRNAs: small RNAs with a big role in gene regulation. He L, Hannon GJ, Nature reviews 2004 5 7 522 531 10.1038/nrg1379 15211354 (Pubitemid 38868508)
3. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Cell Res 2008 18 10 997 1006 10.1038/cr.2008.282 18766170
4. Circulating microRNAs as stable blood-based markers for cancer detection. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Proc Natl Acad Sci USA 2008 105 30 10513 10518 10.1073/pnas.0804549105 18663219
5. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE, Gynecol Oncol 2009 112 1 55 59 10.1016/j.ygyno.2008.08.036 18954897
6. Serum microRNAs are promising novel biomarkers. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, PLoS One 2008 3 9 3148 10.1371/journal.pone.0003148 18773077
7. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ, Proc Natl Acad Sci USA 2009 106 11 4402 4407 10.1073/pnas.0813371106 19246379
8. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H, Cancer Lett 2012 316 2 196 203 10.1016/j.canlet.2011.10.034 22169097
9. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Eur J Cancer 2011 47 5 784 791 10.1016/j.ejca.2010.10.025 21112772
10. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, Zhao C, Tao Y, Xu W, Molecular medicine reports 2012 5 6 1514 1520 22406928
11. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX, Journal of molecular medicine (Berlin, Germany) 2010 88 7 709 717 10.1007/s00109-010-0617-2
12. Circulating microRNAs in plasma of patients with gastric cancers. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Br J Cancer 2010 102 7 1174 1179 10.1038/sj.bjc.6605608 20234369
13. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Gritti I, Banfi G, Roi GS, Pharmacol Res 2000 41 3 265 281 10.1006/phrs.1999. 0586 10675278 (Pubitemid 30663131)
14. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Kageyama T, Cell Mol Life Sci 2002 59 2 288 306 10.1007/s00018-002-8423-9 11915945 (Pubitemid 34169515)
15. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. Ning PF, Liu HJ, Yuan Y, World J Gastroenterol 2005 11 17 2545 2548 15849808 (Pubitemid 40704267)
16. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. Sun LP, Gong YH, Wang L, Yuan Y, World J Gastroenterol 2007 13 48 6562 6567 10.3748/wjg.13.6562 18161928
17. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y, J Gastroenterol Hepatol 2009 24 4 652 657 10.1111/j.1440-1746.2008. 05666.x 19175831
18. Over- and under-expressed microRNAs in human colorectal cancer. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M, Int J Oncol 2009 34 4 1069 1075 19287964
19. A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Proc Natl Acad Sci USA 2006 103 7 2257 2261 10.1073/pnas.0510565103 16461460 (Pubitemid 43271657)
20. Relationship between let-7a and gastric mucosa cancerization and its significance. Zhu YM, Zhong ZX, Liu ZM, World J Gastroenterol 2010 16 26 3325 3329 10.3748/wjg.v16.i26.3325 20614490
21. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY, RNA (New York, NY 2008 14 11 2348 2360 10.1261/rna.1034808
22. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, Zhang Q, Dong L, Liu Y, Dong J, Oncol Rep 2012 27 3 685 694 22134529
23. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Nat Cell Biol 2011 14 2 159 167 10.1038/ncb2396 22179046
24. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Zhang X, Cui L, Ye G, Zheng T, Song H, Xia T, Yu X, Xiao B, Le Y, Guo J, Tumour Biol 2012 33 6 2349 2355 10.1007/s13277-012-0497-x 22926798
25. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Lauren P, Acta Pathol Microbiol Scand 1965 64 31 49 14320675
26. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Gong YH, Sun LP, Jin SG, Yuan Y, Eur J Clin Microbiol Infect Dis 2010 29 7 907 911 10.1007/s10096-010-0944-9 20440530
27. Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs. He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y, J Gastroenterol Hepatol 2011 26 6 1039 1046 10.1111/j.1440-1746.2011. 06692.x 21303408
28. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S, Zhang C, Clin Sci (Lond) 2010 119 2 87 95 10.1042/CS20090645
29. Plasma miR-208 as a biomarker of myocardial injury. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N, Clin Chem 2009 55 11 1944 1949 10.1373/clinchem.2009.125310 19696117
30. Circulating microRNAs in breast cancer and healthy subjects. Zhu W, Qin W, Atasoy U, Sauter ER, BMC research notes 2009 2 89 10.1186/1756-0500-2-89 19454029
31. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M, PLoS One 2009 4 5 5532 10.1371/journal.pone.0005532 19440243
32. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Hussein FK, Nizar B, Mehdi N, Philippe L, Mohammad FK, Rabih B, Eva H, Ahmad D, Nader H, Rim ED, J Transl Med 2013 11 1 31 10.1186/1479-5876-11-31 23391324
33. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, Jeyaseelan K, J Biol Chem 2010 285 38 29223 29230 10.1074/jbc.M110.144576 20628061
34. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T, Gastroenterology 2006 130 7 2113 2129 10.1053/j.gastro.2006.02.057 16762633 (Pubitemid 43816961)
35. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, Li L, Huang DD, Ding J, Shen F, J Hepatol 2009 50 2 358 369 19070389
36. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin. Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, Biochem Biophys Res Commun 2012 420 4 787 792 10.1016/j.bbrc.2012.03.075 22459450
37. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Diakos C, Zhong S, Xiao Y, Zhou M, Vasconcelos GM, Krapf G, Yeh RF, Zheng S, Kang M, Wiencke JK, Blood 2010 116 23 4885 4893 10.1182/blood-2009-02- 206706 20807887
38. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F, Br J Cancer 2003 88 8 1239 1247 10.1038/sj.bjc.6600877 12698190 (Pubitemid 36606340)
39. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Webb PM, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, Coleman MP, De Backer G, Forman D, Gastroenterology 1994 107 5 1335 1344 7926498 (Pubitemid 24328270)
40. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Sangokoya C, Telen MJ, Chi JT, Blood 2010 116 20 4338 4348 10.1182/blood-2009-04-214817 20709907
41. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Liu Z, Xiao B, Tang B, Li B, Li N, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Microbes and infection / Institut Pasteur 2010 12 11 854 863 10.1016/j.micinf.2010.06.002 20542134
42. miRNAs as Modulators of Angiogenesis. Landskroner-Eiger S, Moneke I, Sessa WC, Cold Spring Harbor perspectives in medicine 2013 3 2
43. A comprehensive analysis of precursor microRNA cleavage by human Dicer. Feng Y, Zhang X, Graves P, Zeng Y, RNA New York, NY 2012 18 11 2083 2092
44. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, Kamangar F, Abnet CC, Boffetta P, Engstrand L, PLoS One 2011 6 10 26957 10.1371/journal.pone.0026957 22066020
45. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu HM, Lin JT, Dig Dis Sci 2009 54 11 2377 2384 10.1007/s10620-009-0947-5 19731026
46. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, Chavez A, Cardenas V, Clin Gastroenterol Hepatol 2006 4 3 306 314 10.1016/j.cgh.2005.11.003 16527693 (Pubitemid 43343886)
47. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Kang JM, Kim N, Yoo JY, Park YS, Lee DH, Kim HY, Lee HS, Choe G, Kim JS, Jung HC, Helicobacter 2008 13 2 146 156 10.1111/j.1523-5378. 2008.00592.x 18321304 (Pubitemid 351347663)